Sign In | Join Free | My
China Guangzhou Meisi New Material Co.,Ltd logo
Guangzhou Meisi New Material Co.,Ltd
Guangzhou Meisi New Material High quality, Best service, Reasonable price.
Verified Supplier

3 Years

Home > Active Pharmaceutical Ingredients >

139110-80-8 Zanamivir Hydrate

Guangzhou Meisi New Material Co.,Ltd
Trust Seal
Verified Supplier
Credit Check
Supplier Assessment

139110-80-8 Zanamivir Hydrate

Brand Name : Meisi New Material

Place of Origin : China

MOQ : 100000KG

Payment Terms : T/T

Delivery Time : 5-8work days

Contact Now


Full English name:3-acetamido-4-(diaminomethylideneamino)-2-(1,2,3-trihydroxypropyl)-3,4-dihydro-2H-pyran-6-carboxylic acid hydrate

Chemical name: (2R, 3R, 4S) - 3-acetylamino-4 - (aminoiminomethylamino) - 2 - [(1R, 2R) - 1,2,3-trihydroxypropyl] - 3,4-dihydro-2h-pyran-6-carboxylic acid

CAS No:139110-80-8
Molecular formula : C12H20N4O7
Molecular weight : 332.31

Physical and chemical properties:

Colorless crystal, melting point > 240 ℃ (decomposition), [α] D20 + 41.0 ° (C = 0.9, H2O), soluble in water, density 1.75 ± 0.1g/cm3

Product category:

Zanamivir is a kind of anti influenza virus drug developed by biota company in Australia. It was marketed in the UK in 1999. Its trade name is Relenza. Zanamivir is a neuraminidase inhibitor. It can change the aggregation and release of influenza virus in infected cells by inhibiting neuraminidase of influenza virus. Neuraminidase is the key enzyme of respiratory virus replication, which can break the chemical bond between sialic acid and cell surface protein, so as to separate the newly generated virus particles from the infected cells, and then infect the nearby normal cells. Inhibition of neuraminidase can prevent the virus from spreading to other cells in the respiratory tract. This product can be used to treat and prevent the spread of influenza virus in the respiratory tract, and it is very effective within 48 hours after the onset of symptoms. This product is a dry powder inhaler, distributed in the respiratory tract after inhalation, such as nasopharynx, which can effectively inhibit neuraminidase activity. Oral administration of this product is invalid.

Product Tags:

active pharma ingredients


medicine active ingredient

 139110-80-8 Zanamivir Hydrate Manufactures

139110-80-8 Zanamivir Hydrate Images

Inquiry Cart 0
Send your message to this supplier
*To: Guangzhou Meisi New Material Co.,Ltd
Characters Remaining: (0/3000)